Insider · CIK 0001388325
Novo Holdings A/S
Files at: ETTX, CRVS, KALV, HTGM, ANAB, APEN, RETA, OPHT and 5 more. On EDGAR ↗
Reported trades — common stock
| Trade | Reported (ET) | Company | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 28, 2018 PForm 4 → | Oct 1, 4:36 pm EDT | Entasis Therapeutics Holdings Inc.ETTX | 1,089,835 | $15.00 | $16,347,525 | 2,181,843 | +99.8% | plan? |
| Sep 28, 2018 CForm 4 → | Oct 1, 4:36 pm EDT | Entasis Therapeutics Holdings Inc.ETTX | 1,092,008 | — | — | 1,092,008 | — | plan? |
| Mar 12, 2018 PForm 4 → | Mar 13, 5:12 pm EDT | Corvus Pharmaceuticals, Inc.CRVS | 1,176,470 | $8.50 | $9,999,995 | 4,420,516 | +36.3% | plan? |
| Oct 10, 2017 SForm 4 → | Oct 12, 5:21 pm EDT | KalVista Pharmaceuticals, Inc.KALV | 2,725,283 | $9.64 | $26,271,182 | 0 | −100% | plan? |
| Sep 13, 2017 SForm 4/A → | Sep 18, 7:04 pm EDT | KalVista Pharmaceuticals, Inc.KALV | 176,644 | $7.21 | $1,273,956 | 2,725,283 | −6.09% | plan? |
| Sep 13, 2017 SForm 4 → | Sep 15, 7:18 pm EDT | KalVista Pharmaceuticals, Inc.KALV | 176,647 | $7.21 | $1,273,980 | 2,725,280 | −6.09% | plan? amended |
| Aug 23, 2017 SForm 4 → | Aug 25, 7:17 pm EDT | HTG MOLECULAR DIAGNOSTICS, INCHTGM | 1,149,813 | $1.81 | $2,085,985 | 0 | −100% | plan? |
| Aug 21, 2017 SForm 4 → | Aug 21, 5:11 pm EDT | ANAPTYSBIO INCANAB | 356,300 | $21.10 | $7,518,251 | 1,936,604 | −15.5% | plan? |
| Aug 18, 2017 SForm 4 → | Aug 22, 7:25 pm EDT | HTG MOLECULAR DIAGNOSTICS, INCHTGM | 80,586 | $2.07 | $166,988 | 1,199,599 | −6.29% | plan? |
| Aug 14, 2017 SForm 4 → | Aug 16, 4:56 pm EDT | ANAPTYSBIO INCANAB | 178,600 | $21.16 | $3,778,481 | 2,292,904 | −7.23% | plan? |
| Aug 4, 2017 SForm 4 → | Aug 8, 6:08 pm EDT | ANAPTYSBIO INCANAB | 491,294 | $21.12 | $10,377,406 | 2,471,504 | −16.6% | plan? |
| Aug 1, 2017 SForm 4 → | Aug 3, 5:21 pm EDT | ANAPTYSBIO INCANAB | 70,706 | $23.31 | $1,647,947 | 2,962,798 | −2.33% | plan? |
| Jul 24, 2017 SForm 4 → | Jul 26, 7:22 pm EDT | Apollo Endosurgery, Inc.APEN | 50,130 | $6.90 | $345,766 | 1,301,842 | −3.71% | plan? |
| Jun 23, 2017 PForm 4 → | Jun 27, 4:52 pm EDT | Corvus Pharmaceuticals, Inc.CRVS | 20,000 | $10.95 | $219,000 | 3,244,046 | +0.62% | plan? |
| Jun 13, 2017 SForm 4 → | Jun 14, 4:39 pm EDT | REATA PHARMACEUTICALS INCRETA | 61,000 | $25.11 | $1,531,926 | 592,794 | −9.33% | plan? |
| Jun 8, 2017 SForm 4 → | Jun 12, 6:12 pm EDT | REATA PHARMACEUTICALS INCRETA | 222,503 | $25.71 | $5,719,779 | 653,794 | −25.4% | plan? |
| Jun 5, 2017 SForm 4 → | Jun 7, 7:01 pm EDT | REATA PHARMACEUTICALS INCRETA | 89,497 | $28.24 | $2,527,394 | 876,297 | −9.27% | plan? |
| May 10, 2017 SForm 4 → | May 11, 6:00 pm EDT | Apollo Endosurgery, Inc.APEN | 105,000 | $5.63 | $590,703 | 1,351,972 | −7.21% | plan? |
| Jan 31, 2017 PForm 4 → | Feb 1, 4:22 pm EST | ANAPTYSBIO INCANAB | 50,000 | $15.00 | $750,000 | 3,033,504 | +1.68% | plan? |
| Jan 31, 2017 CXForm 4 → | Feb 1, 4:22 pm EST | ANAPTYSBIO INCANAB | 2,983,504 | — | — | 2,983,504 | — | plan? |
| Dec 14, 2016 SForm 4 → | Dec 16, 6:29 pm EST | Ophthotech Corp.OPHT | 3,610,487 | $4.87 | $17,598,385 | 0 | −100% | plan? |
| Oct 31, 2016 PForm 4 → | Nov 2, 4:54 pm EDT | Ra Pharmaceuticals, Inc.RARX | 246,154 | $13.00 | $3,200,002 | 2,031,562 | +13.8% | plan? |
| Oct 31, 2016 CForm 4 → | Nov 2, 4:54 pm EDT | Ra Pharmaceuticals, Inc.RARX | 1,785,408 | — | — | 1,785,408 | — | plan? |
| Oct 25, 2016 PForm 4 → | Oct 26, 4:46 pm EDT | iRhythm Technologies, Inc.IRTC | 100,000 | $17.00 | $1,700,000 | 2,124,448 | +4.94% | plan? |
| Oct 25, 2016 CForm 4 → | Oct 26, 4:46 pm EDT | iRhythm Technologies, Inc.IRTC | 2,007,449 | — | — | 2,024,448 | — | plan? |
| Sep 9, 2016 PForm 4 → | Sep 13, 11:48 am EDT | CoLucid Pharmaceuticals, Inc.CLCD | 100,000 | $20.00 | $2,000,000 | 3,156,563 | +3.27% | plan? |
| Jul 11, 2016 SForm 4 → | Jul 13, 6:26 pm EDT | Tobira Therapeutics, Inc.TBRA | 59,067 | $12.02 | $710,118 | 1,875,905 | −3.05% | plan? |
| Jul 5, 2016 SForm 4 → | Jul 7, 6:46 pm EDT | Tobira Therapeutics, Inc.TBRA | 92,119 | $12.20 | $1,124,131 | 1,934,972 | −4.54% | plan? |
| Jun 28, 2016 SForm 4 → | Jun 30, 6:01 pm EDT | Tobira Therapeutics, Inc.TBRA | 66,814 | $13.04 | $870,941 | 2,027,091 | −3.19% | plan? |
| Jun 6, 2016 SForm 4 → | Jun 7, 5:08 pm EDT | Tobira Therapeutics, Inc.TBRA | 187,500 | $10.37 | $1,943,906 | 2,093,905 | −8.22% | plan? |
| Jun 1, 2016 CForm 4/A → | Aug 5, 11:41 am EDT | REATA PHARMACEUTICALS INCRETA | 215,794 | — | — | 965,794 | — | plan? |
| Jun 1, 2016 PForm 4 → | Jun 2, 4:17 pm EDT | REATA PHARMACEUTICALS INCRETA | 750,000 | $11.00 | $8,250,000 | 750,000 | — | plan? amended |
| May 24, 2016 SForm 4 → | May 25, 5:17 pm EDT | Ophthotech Corp.OPHT | 1,300,000 | $49.00 | $63,700,000 | 3,610,489 | −26.5% | plan? |
| May 12, 2016 PForm 4 → | May 16, 5:01 pm EDT | Corvus Pharmaceuticals, Inc.CRVS | 70,000 | $10.00 | $700,000 | 3,224,046 | +2.22% | plan? |
| Mar 29, 2016 PForm 4 → | Mar 30, 1:07 pm EDT | Corvus Pharmaceuticals, Inc.CRVS | 666,666 | $15.00 | $9,999,990 | 3,154,046 | +26.8% | plan? |
| Mar 29, 2016 CForm 4 → | Mar 30, 1:07 pm EDT | Corvus Pharmaceuticals, Inc.CRVS | 2,487,380 | — | — | 2,487,380 | — | plan? |
| Mar 2, 2016 SForm 4 → | Mar 4, 6:34 pm EST | Tobira Therapeutics, Inc.TBRA | 190,000 | $6.80 | $1,292,086 | 2,281,405 | −7.69% | plan? |
| Nov 17, 2015 SForm 4 → | Nov 19, 5:55 pm EST | Tobira Therapeutics, Inc.TBRA | 225,000 | $9.79 | $2,203,079 | 2,471,405 | −8.34% | plan? |
| Jun 18, 2015 SForm 4 → | Jun 22, 6:22 pm EDT | Flexion Therapeutics IncFLXN | 150,000 | $20.61 | $3,091,973 | 2,133,131 | −6.57% | plan? |
| May 11, 2015 PForm 4 → | May 12, 5:32 pm EDT | HTG MOLECULAR DIAGNOSTICS, INCHTGM | 365,106 | $14.00 | $5,111,484 | 1,280,185 | +39.9% | plan? |
| May 11, 2015 CXForm 4 → | May 12, 5:32 pm EDT | HTG MOLECULAR DIAGNOSTICS, INCHTGM | 915,079 | — | — | 915,079 | — | plan? |
| May 11, 2015 PForm 4 → | May 12, 5:31 pm EDT | CoLucid Pharmaceuticals, Inc.CLCD | 1,300,000 | $10.00 | $13,000,000 | 3,056,563 | +74.0% | plan? |
| May 11, 2015 CForm 4 → | May 12, 5:31 pm EDT | CoLucid Pharmaceuticals, Inc.CLCD | 1,756,563 | — | — | 1,756,563 | — | plan? |
| May 4, 2015 PForm 4 → | May 6, 6:32 pm EDT | Tibira Therapeutics, Inc.TBRA | 838,041 | $10.62 | $8,899,995 | 2,696,405 | +45.1% | plan? |
| Mar 25, 2015 XForm 4 → | Mar 26, 5:03 pm EDT | Ophthotech Corp.OPHT | 13,668 | $0.059 | $806 | 4,910,487 | — | plan? |
| Mar 5, 2015 SForm 4 → | Mar 9, 7:01 pm EDT | Ophthotech Corp.OPHT | 1,005,000 | $51.75 | $52,008,750 | 4,896,819 | −17.0% | plan? |
Reported trades — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Company | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 28, 2018 CForm 4 → | Oct 1, 4:36 pm EDT | Entasis Therapeutics Holdings Inc.ETTX | 21,237,288 | — | — | 0 | — | |
| Jun 22, 2017 SForm 4 → | Jun 23, 4:34 pm EDT | REATA PHARMACEUTICALS INCRETA | 1,200,000 | $25.00 | $30,000,000 | 1,201,969 | — | |
| Jan 31, 2017 CXForm 4 → | Feb 1, 4:22 pm EST | ANAPTYSBIO INCANAB | 3,019,066 | — | — | 0 | — | |
| Oct 31, 2016 CForm 4 → | Nov 2, 4:54 pm EDT | Ra Pharmaceuticals, Inc.RARX | 1,785,408 | — | — | 0 | — | |
| Oct 25, 2016 CForm 4 → | Oct 26, 4:46 pm EDT | iRhythm Technologies, Inc.IRTC | 2,007,449 | — | — | 0 | — | |
| Jun 1, 2016 CForm 4/A → | Aug 5, 11:41 am EDT | REATA PHARMACEUTICALS INCRETA | 215,794 | — | — | 2,401,969 | — | |
| Mar 29, 2016 CForm 4 → | Mar 30, 1:07 pm EDT | Corvus Pharmaceuticals, Inc.CRVS | 2,487,380 | — | — | 0 | — | |
| May 11, 2015 CXForm 4 → | May 12, 5:32 pm EDT | HTG MOLECULAR DIAGNOSTICS, INCHTGM | 915,079 | — | — | 0 | — | |
| May 11, 2015 CForm 4 → | May 12, 5:31 pm EDT | CoLucid Pharmaceuticals, Inc.CLCD | 1,756,563 | — | — | 0 | — | |
| Mar 25, 2015 XForm 4 → | Mar 26, 5:03 pm EDT | Ophthotech Corp.OPHT | 13,668 | — | — | 0 | — |